Latest Lead News

Metallium Limited’s US subsidiary has inked a decade-long off-take agreement with Indium Corporation, setting a firm commercial foundation for supplying critical metals like gallium and germanium recovered through innovative recycling technology.

Enlitic has secured a $250,000 data migration contract with St. Jude Children’s Research Hospital, marking its first foray into paediatric healthcare and opening doors for its AI-powered platform Ensight.

St George Mining has partnered with Spain’s Tecnicas Reunidas to test advanced processing technology on its Araxá rare earths, aiming to unlock European markets alongside existing US and Brazilian alliances.

Firebrick Pharma has successfully secured $1.5 million through a strategic placement, positioning itself to accelerate business development and launch new products in key markets.

Cleo Diagnostics has completed blood sample collection for its pivotal U.S. clinical trial, advancing its Pre-Surgical Ovarian Cancer Test closer to FDA submission.

Regener8 Resources advances its due diligence on the Srebrenica North Project in Bosnia-Herzegovina, revealing promising high-grade silver, lead, zinc, and antimony mineralisation at the Dolovi tenement. Historical data and recent sampling highlight significant exploration potential near established mines.

KMD Brands has reported solid half-year growth and launched a $65.3 million equity raising alongside debt refinancing to support its Next Level transformation strategy.

TechGen Metals has reported a significant copper intersection of 20 metres at 1.14% Cu at its Mt Boggola Project, with further diamond core assay results pending and a follow-up drilling campaign in the works.

Cyclopharm Limited is rapidly expanding its Technegas® lung imaging technology across the US, securing new contracts and advancing clinical guideline recognition that could boost adoption.

Bayan Mining and Minerals has secured membership in the U.S. Defense Industrial Base Consortium, opening doors to strategic partnerships and funding for its rare earth technologies, including a patented yttrium upgrade process. This move positions Bayan at the forefront of efforts to secure critical mineral supply chains vital to U.S. national security.

Paradigm Biopharmaceuticals has achieved 50% patient enrolment in its pivotal Phase 3 trial for injectable pentosan polysulfate sodium, advancing steadily towards an interim analysis expected in August 2026.

Battery Age Minerals has expanded its Apex Germanium-Gallium Project in Utah by 40%, staking 51 new mining claims adjacent to the historic Apex Mine. This move strengthens its foothold in a vital US critical minerals hub amid growing demand for semiconductor and defence supply chains.